GSK and Save the Children Form Unique Partnership to Save the Lives of One Million Children Over Five Years
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 05/09/13 -- An ambitious new partnership to save the lives of a million of the world's poorest children has been launched by GSK and Save the Children. This unique collaboration will see the two organizations work together in a very different way: sharing expertise, resources, reach, and influence to tackle some of the leading causes of childhood deaths.
Amongst the key initiatives are the transformation of an antiseptic, used in mouthwash into a life-saving product for newborns, and the roll-out of a powder-form of an antibiotic in child friendly doses to help fight pneumonia - one of the main killers of children under five.
For the first time, Save the Children will be involved in helping GSK to research and develop medicines for children, with a seat on a new paediatric R&D board to accelerate progress on innovative life-saving interventions for under-fives, and to identify ways to ensure the widest possible access in the developing world. GSK will be able to leverage Save the Children's child health expertise and on-the-ground experience to reach children in the most remote and marginalized communities with basic healthcare.
The GSK-Save the Children partnership will also focus on widening vaccine coverage to the poorest children, increasing investment in health workers, as well as developing a low-cost nutritional product to help combat child malnutrition.
Flagship programs will run initially in Democratic Republic of Congo and Kenya. These will be closely monitored and the evidence on how to save children's lives at scale will be used to replicate programs in other countries within Sub-Saharan Africa, Asia and Latin America.
While good progress has been made in recent years, almost seven million children died in 2011 through lack of access to basic healthcare, vaccines or nutritious food. Through these and other initiatives, the partnership aims to help save the lives of one million children in the next five years.
Justin Forsyth, the Chief Executive of Save the Children, UK, said: "This ground breaking partnership involves both organisations working in genuinely new ways to save the lives of a million children. In the past Save the Children may not have embarked on a collaboration with a pharmaceutical company like GSK. But we believe we can make huge gains for children if we harness the power of GSK's innovation, research and global reach."
Sir Andrew Witty, CEO of GSK said: "A partnership of this scale gives us an opportunity to do something amazing - to save the lives of one million children and to transform the lives of millions more. At GSK we are motivated by developing innovative life-saving medicines and getting them to the people that need them. By joining forces with Save the Children, we can amplify these efforts to create a new momentum for change and stop children dying from preventable diseases. I hope this partnership inspires GSK employees and sets a new standard for how companies and NGOs can work together towards a shared goal."
Key features of the partnership are:
Save the Children and GSK have been working together for eight years on a number of public health projects, including GSK's initiative to reinvest 20 per cent of the profits it makes in least developed-countries in community programs to strengthen healthcare infrastructure, primarily through the training of community health workers.
About Save the Children
Save the Children is the world's leading independent organization for children, delivering programs and improving children's lives in 120 countries worldwide. Working toward a world in which every child attains the right to survival, protection, development, and participation, Save the Children's mission is to inspire breakthroughs in the way the world treats children and to achieve immediate and lasting change in their lives. Learn more at and .
Contacts:
Save the Children
Bryna Jones
Manager, Communications
(416) 221-5501 x222 or Cell: (647) 273-7134
Toll Free: 1-800-668-5036 x222
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.05.2013 - 13:35 Uhr
Sprache: Deutsch
News-ID 1225710
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
TORONTO, ONTARIO
Phone:
Kategorie:
Non Profits
Anmerkungen:
Diese Pressemitteilung wurde bisher 224 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GSK and Save the Children Form Unique Partnership to Save the Lives of One Million Children Over Five Years
"
steht unter der journalistisch-redaktionellen Verantwortung von
Save the Children Canada (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
